📌 Key Takeaways
- Topic: What Is Micro Silica? Properties, Specifications and Uses in Concrete and Refractories
- Keywords: silica adsorbent
- Published: 2026-11-20 09:22:38
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
In spite of the advantages of solvent-free processes, solvent-based techniques offer a more widespread choice for filling the pores of the carriers. Each method listed here consists of two steps. First, mixing the drug solution and carrier, then removing the solvent [ 36 ]. The loading cycles can be repeated as many times as desired to increase the charging efficiency [ 20, 36 ]. These techniques can be effectively applied to molecules both with great and poor aqueous solubility [ 37 ]. However, removing the solvent residue at the end of the process is essential, owing to the toxicity of usually used organic solvents [ 56 ], and it is normally better to select a less toxic organic solvent, if possible [ 37, 56 ]. The adsorption of the API is also influenced by the properties of the solvent, such as viscosity or surface tension. This group includes the adsorption approach, the incipient wetness approach, the solvent evaporation method, and the use of liquid and supercritical CO 2. The adsorption technique (solvent immersion method) is a low-energy process, but the pores can be filled effectively only if the API reaches a high concentration in the solvent [ 37 ]. The carrier system is immersed in the concentrated drug solution, while the liquid fills the pores owing to capillary forces. The mesopores are then separated from the solution by filtration or centrifugation. Finally, the pores are dried under reduced pressure [ 2, 36, 37 ]. Drug loading abilities can be seen for some APIs by this loading approach, in the following figure ( Figure 1 ). During the incipient wetness impregnation, a greatly concentrated drug solution is added dropwise onto the surface of the mesopores, in a nearly equal volume to the pore volume of the carrier [ 37 ]. In this case, the pores are filled with liquid also owing to the capillary forces. Then the pores are dried out at a higher temperature and under reduced pressure [ 2, 36, 37 ]. Nevertheless, the third approach, solvent evaporation, is the most widely used because it can be applied to a wide range of molecules, regardless of their solubility, making it fitting for higher therapeutic doses as well. It is not necessary to prepare a concentrated solution since the concentration gradually increases during the process (owing to the evaporation of the solvent). During the process, the drug should be dissolved in a volatile organic solvent, which is mixed with the carrier system [ 20 ]. All solvents are then eliminated by quick evaporation [ 37 ], while the drug is absorbed into the pores of the drug carrier [ 36, 37 ]. The use of supercritical CO 2 brings about more productive and deeper pore filling compared to other solvents. In this state, neither a liquid phase nor a gas phase exists. It combines the brilliant diffusion capacity of gases and the excellent solvation capacity of liquids. In addition, it is non-toxic, non-flammable, and can be readily eliminated from the system. A cost-effective choice can be liquid CO 2, which is a similarly effective solvent [ 36, 37 ].
Silica as a Food Additive: Uses, E551 Approval and Safety
- Silica Tapped Density: Definition, Measurement and Typical Values
- Even though MSNs can usually be recognized as secure products, their use during therapy may cause side impacts in the body [ 1, 2, 29 ]. Due to their small size and large surface area, they may tend to accumulate in the body, or certain organs (liver, spleen, kidney, lung) and may even be toxic in higher concentrations, which is a clear disadvantage [ 1, 4, 27 ]. The silanol groups (Si-OH) on their surface can interact with the phospholipid layer of the cell membrane, thereby causing cell lysis or, in extreme cases, hemolysis [ 4, 8 ]. In severe cases, the lack of hemocompatibility can also cause issues [ 2 ]. Overall, indications of cytotoxicity, haemotoxicity, and genotoxicity were also found [ 4, 8 ]. That is why the biocompatibility of all comparable preparations must be strictly controlled [ 2, 4, 27 ]. The physicochemical features (particle size, particle morphology, surface chemistry, pore structure, etc.) of nanocarriers also have a major impact on toxicity [ 2, 4, 8, 30 ]. Additionally, further attention must be paid to the biological influences of their decomposition products, because they may also cause unwanted side influences [ 1 ]. The breakdown of silica nanoparticles in the body can take up to a few days. The opening hydration is followed by hydrolysis, and, in the end, they are excreted in the urine in the form of silicic acid [ 1 ]. Nevertheless, the literature is contradictory in this regard [ 31 ]. Some experiments show no considerable cytotoxic effect [ 18, 31 ], while other experiments say otherwise [ 23, 32 ]. For example, an in vitro study was performed with multiple concentrations, surfaces, and particle sizes (60 nm, 100 nm, 300 nm) of MSNs, with an exposure time of 72 h [ 18 ]. This study shown no significant cytotoxic influence in any of the cell lines tested (human cervical (HeLA), epithelial lung (A549), and glioblastoma (U251)) [ 18 ]. Ismail et al. investigated the cytotoxic effect of silica nanoparticles in vivo in mouse models [ 33 ]. Amorphous silica nanoparticles were administered to the animals orally, at a dose of 150 mg/kg/day, for 3 months. Based on these mouse models, no toxic effects were detected under sub-chronic treatment of the nanoparticles [ 31 ]. In another study, particle size (15 nm, 60 nm, 200 nm) dependent impact was observed on cellular viability in all four cell lines tested (THP-1 derived macrophages, A549 epithelial cells, HaCaT keratinocytes, and NRK-52E kidney cells) [ 23 ]. Smaller particles caused notable toxicity on each cell line, after the exposure time of 24 h, in contrast to the larger particles, which demonstrated no cytotoxic impact [ 23 ]. A comparable outcome has been published to verify the toxic characteristic of mesoporous silica. In this in vitro study, the researchers investigated the effect of MSNs with an average size of 7 nm on cell viability at three different concentrations. After 72 h of exposure, only the highest concentration (62.5 µg/mL) caused a substantial decrease in cell viability of human lung fibroblast cells. This toxicity occurred in a time- and dose-dependent manner [ 32 ]. In an in vivo mouse model, MacCuaig et al. presented coating-dependent impacts after repeated intravenous administration of MSNs. Chitosan-coated MSNs induced minor organ changes and were the most biocompatible. Uncoated and especially PEG-coated MSNs (especially 2K PEG) moderately augmented pre-existing vascular or organ lesions, implying that PEGylation has the potential to augment chronic risks, while chitosan enables safer long-term use [ 34 ]. An in vitro study of Barguilla et al. exposed epithelial lung cells to bare, PEG-functionalized, or galacto-oligosaccharide-functionalized MSNs for eight weeks. There was no reported long-term DNA damage, but malignant-like alterations like anchorage-independent growth, boosted migration/invasion, and secretome-facilitated tumor promotion were triggered by PEG- and GAL-functionalized MSNs. Naked MSNs did not cause such alterations and were determined to be safer [ 35 ]. Coating, on the whole, exerts a significant impact on the safety of MSNs. Uncoated MSNs are relatively innocuous; the most biocompatible coatings were achieved with chitosan, but PEG and carbohydrate functionalization can be dangerous in the long run, from vascular toxicity in vivo to tumor-promoting activity in vitro [ 34, 35 ].
- Foundry Silica Sand: AFS Grain Fineness, Specifications and Uses
- Quartz CAS 14808-60-7: Identification, Hazards and Regulatory Information
- PPG Hi-Sil: Precipitated Silica Product Range and Applications
- Nanocarriers can be divided into two principal groups: organic and inorganic types. The organic group contains lipid nanocarriers, liposomes, polymeric nanoparticles, dendrimers, etc. In the case of the carriers in this group, the limited volume of delivered active pharmaceutical ingredient (API) is a clear disadvantage, along with decreased stability, and good sensitivity to temperature, pH, and enzymes in a physiological environment. The inorganic group contains metal oxide-, carbon-, silicon-, silica-, and quantum dot-based nanocarriers. Their benefits are greater stability and well-tunable physicochemical properties, but their accumulation in the body may be a key question of their applicability. Silica nanoparticles (SNP) are silicon dioxide (SiO 2 ) nanoparticles in an amorphous state and have excellent potential in the pharmaceutical industry and drug development due to their special properties. According to pore size, the most common, most well-liked, and most effective type of silica nanocarriers are the mesoporous silica nanoparticles (MSNs) [ 1 ].
Silica as an Anti-Caking Agent: How It Works and Where It Is Used
What is silica (SiO₂)?
quartz sand for photovoltaic
What is the difference between fumed silica and precipitated silica?
white carbon black
What drives silica raw material prices?
silica wholesale Informed Consent Statement
Cite this article: Silica Raw Materials News. "Silica for Rheology Control: How to Select the Right Silica and Dosage
." Published 2026-11-20 09:22:38.
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.